Evidence map›Paper›PMID 35265059›Full record

ReviewFrontiers in microbiology2022

Bacterial and Host Determinants of Group B Streptococcal Infection of the Neonate and Infant.

Anna Furuta, Alyssa Brokaw, Gygeria Manuel, Matthew Dacanay, Lauren Marcell, Ravin Seepersaud, Lakshmi Rajagopal, Kristina Adams Waldorf

Abstract readReview
In one paragraph

Review in Frontiers in microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Identification of glyoxalase A in group BInfection and immunity · 2025
    Article
  12. Review
  13. Article
  14. Identification of Glyoxalase A in Group BbioRxiv : the preprint server for biology · 2024
    Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Neonatal Group BSaudi medical journal · 2024
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Anna FurutaCenter for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA, United States.
Alyssa BrokawCenter for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA, United States.
Gygeria ManuelMorehouse School of Medicine, Atlanta, GA, United States.
Matthew DacanayDepartment of Obstetrics & Gynecology, University of Washington, Seattle, WA, United States.
Lauren MarcellDepartment of Obstetrics & Gynecology, University of Washington, Seattle, WA, United States.
Ravin SeepersaudCenter for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA, United States.
Lakshmi RajagopalCenter for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA, United States.
Kristina Adams WaldorfDepartment of Global Health, University of Washington, Seattle, WA, United States.

Funding

Washington National Primate Research CenterP51OD010425 · OD · UNIVERSITY OF WASHINGTON · PI Mari Ostendorf · 2012 to 2026
$201.8M
WaNPRC Macaca nemestrina SPF Breeding ColonyU42OD011123 · OD · UNIVERSITY OF WASHINGTON · PI Melissa R Berg, Cindy Buckmaster · 2012 to 2026
$34.4M
University of Washington Medical Scientist Training Program: MD/PhDT32GM007266 · NIGMS · UNIVERSITY OF WASHINGTON · PI HORWITZ, MARSHALL S. · 1985 to 2023
$30.4M
Diseases of Public Health Importance Training GrantT32AI007509 · NIAID · UNIVERSITY OF WASHINGTON · PI LUND, JENNIFER M · 1997 to 2024
$6.3M
Role of the hyaluronidase in GBS VirulenceR01AI133976 · NIAID · SEATTLE CHILDREN'S HOSPITAL · PI ADAMS WALDORF, KRISTINA M., RAJAGOPAL, LAKSHMI · 2017 to 2021
$4.5M
Immune Control of Group B Streptococcal PlacentalR01AI145890 · NIAID · SEATTLE CHILDREN'S HOSPITAL · PI ADAMS WALDORF, KRISTINA M., RAJAGOPAL, LAKSHMI · 2019 to 2023
$4.4M
Targeted Inhibition of Interleukin-1 beta to Prevent Preterm BirthR01HD098713 · NICHD · UNIVERSITY OF WASHINGTON · PI ADAMS WALDORF, KRISTINA M., RAJAGOPAL, LAKSHMI · 2020 to 2024
$3.8M
FXIIIA production by mast cells for innate immunityR01AI152268 · NIAID · SEATTLE CHILDREN'S HOSPITAL · PI PILIPONSKY, ADRIAN M, RAJAGOPAL, LAKSHMI · 2020 to 2024
$3.7M
INTERDISCIPLINARY PROGRAM IN BACTERIAL PATHOGENESIST32AI055396 · NIAID · UNIVERSITY OF WASHINGTON · PI FANG, FERRIC C · 2003 to 2019
$2.8M
NIAID NIH HHS R01 AI133976NIAID NIH HHS R01 AI145890NIAID NIH HHS R01 AI152268NIAID NIH HHS T32 AI007509NIAID NIH HHS T32 AI055396NICHD NIH HHS R01 HD098713NIGMS NIH HHS T32 GM007266NIH HHS P51 OD010425NIH HHS U42 OD011123
6 · The paper itself

Abstract

Group B streptococci (GBS) are Gram-positive β-hemolytic bacteria that can cause serious and life-threatening infections in neonates manifesting as sepsis, pneumonia, meningitis, osteomyelitis, and/or septic arthritis. Invasive GBS infections in neonates in the first week of life are referred to as early-onset disease (EOD) and thought to be acquired by the fetus through exposure to GBS

Indexed as

GBSgroup B streptococcusmeningitisneonatesepsis

Identifiers

PMID35265059
PMCPMC8899651

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.